As mutations in SETD2 continue to be identified in a growing list of tumor types (6, 20), it will be important to discern the relative roles of histone versus tubulin methylation in contributing to the underlying mechanisms of particular cancer phenotypes. This evidence concerns the gene SETD2 and cancer.